Business Description
Benevolent AI
ISIN : LU2355630455
Compare
Compare
Traded in other countries / regions
BAI.Netherlands2XA.GermanyBAIVF.USA IPO Date
2022-04-22Description
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.68 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -6.25 | |||||
| Beneish M-Score | 0.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.8 | |||||
| 3-Year EBITDA Growth Rate | -12.8 | |||||
| 3-Year EPS without NRI Growth Rate | -11.1 | |||||
| 3-Year FCF Growth Rate | -27.3 | |||||
| 3-Year Book Growth Rate | -2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 53.38 | |||||
| Future 3-5Y Total Revenue Growth Rate | 70.85 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.76 | |||||
| 9-Day RSI | 17.22 | |||||
| 14-Day RSI | 20.4 | |||||
| 6-1 Month Momentum % | 46 | |||||
| 12-1 Month Momentum % | -56.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.65 | |||||
| Quick Ratio | 3.65 | |||||
| Cash Ratio | 1.46 | |||||
| Days Sales Outstanding | 362.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 5 | |||||
| Shareholder Yield % | 5.34 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1042.98 | |||||
| Net Margin % | -863.21 | |||||
| FCF Margin % | -794.53 | |||||
| ROE % | -51.35 | |||||
| ROA % | -41.65 | |||||
| ROIC % | -77.36 | |||||
| ROC (Joel Greenblatt) % | -173.15 | |||||
| ROCE % | -56.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.34 | |||||
| PB Ratio | 0.44 | |||||
| Price-to-Tangible-Book | 0.58 | |||||
| EV-to-EBIT | -0.11 | |||||
| EV-to-EBITDA | -0.12 | |||||
| EV-to-Revenue | 1.12 | |||||
| EV-to-Forward-Revenue | 1.7 | |||||
| EV-to-FCF | -0.15 | |||||
| Price-to-Net-Current-Asset-Value | 0.66 | |||||
| Price-to-Net-Cash | 6.38 | |||||
| Earnings Yield (Greenblatt) % | -902.75 | |||||
| FCF Yield % | -142.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Benevolent AI Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 8.534 | ||
| EPS (TTM) (€) | -0.623 | ||
| Beta | 0 | ||
| Volatility % | 123.91 | ||
| 14-Day RSI | 20.4 | ||
| 14-Day ATR (€) | 0.046675 | ||
| 20-Day SMA (€) | 0.52515 | ||
| 12-1 Month Momentum % | -56.29 | ||
| 52-Week Range (€) | 0.36 - 1.63 | ||
| Shares Outstanding (Mil) | 124.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Benevolent AI Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Benevolent AI Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Benevolent AI Frequently Asked Questions
What is Benevolent AI(XAMS:BAI)'s stock price today?
The current price of XAMS:BAI is €0.38. The 52 week high of XAMS:BAI is €1.63 and 52 week low is €0.36.
When is next earnings date of Benevolent AI(XAMS:BAI)?
The next earnings date of Benevolent AI(XAMS:BAI) is .
Does Benevolent AI(XAMS:BAI) pay dividends? If so, how much?
Benevolent AI(XAMS:BAI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers